Xin He
Directeur/Bestuurslid bij BIOSINO BIO-TECHNOLOGY AND SCIENCE INCORPORATION
Profiel
Dr. Xin He is an Independent Non-Executive Director at Biosino Bio-Technology & Science, Inc. She is on the Board of Directors at Biosino Bio-Technology & Science, Inc., Elpiscience Biopharmaceuticals, Inc. and Elpiscience Biopharma Ltd.
Dr. He was previously employed as a Chief Executive Officer by RHEI Pharmaceuticals, Inc. She received her graduate degree from Princeton University and a doctorate degree from Yale University.
Actieve functies van Xin He
| Bedrijven | Functie | Begin |
|---|---|---|
| BIOSINO BIO-TECHNOLOGY AND SCIENCE INCORPORATION | Directeur/Bestuurslid | 28-06-2024 |
Elpiscience Biopharma Ltd.
 Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Elpiscience Biopharma Ltd. engages in the development of cutting-edge immunotherapies to fight cancer. Its business scope includes technology research and development, transfer of own technology achievements and provision of related technical advice and technical services of biomedicine and biotechnology; import and export, and wholesale of mechanical equipment, electronic products, instrumentation, and plastic products. The company was founded on September 30, 2017 and is headquartered in Shanghai, China. | Directeur/Bestuurslid | - |
Elpiscience Biopharmaceuticals, Inc.
 Elpiscience Biopharmaceuticals, Inc. BiotechnologyHealth Technology Elpiscience Biopharmaceuticals, Inc. is an investment holding company, which engages in the research and development of immuno-oncology therapies. It focuses on the development of clinical-stage drug candidates namely, ES102, ES014, ES104, and ES009. The company was founded by Xiao Hui Ji and Hong Tao Lu in June 2017 and is headquartered in Shanghai, China. | Directeur/Bestuurslid | 28-12-2019 |
Eerdere bekende functies van Xin He
| Bedrijven | Functie | Einde |
|---|---|---|
RHEI Pharmaceuticals, Inc.
 RHEI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology RHEI Pharmaceuticals, Inc. acquires licenses, develops and commercializes therapies. The company was founded by Harry H. Penner, John W. Childs, Xin Sylvia He and Glenn A. Hopkins in 2008 and is headquartered in New Haven, CT. | Algemeen Directeur | - |
Opleiding van Xin He
| Yale University | Doctorate Degree |
| Princeton University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BIOSINO BIO-TECHNOLOGY AND SCIENCE INCORPORATION | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
RHEI Pharmaceuticals, Inc.
RHEI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology RHEI Pharmaceuticals, Inc. acquires licenses, develops and commercializes therapies. The company was founded by Harry H. Penner, John W. Childs, Xin Sylvia He and Glenn A. Hopkins in 2008 and is headquartered in New Haven, CT. | Health Technology |
Elpiscience Biopharma Ltd.
Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Elpiscience Biopharma Ltd. engages in the development of cutting-edge immunotherapies to fight cancer. Its business scope includes technology research and development, transfer of own technology achievements and provision of related technical advice and technical services of biomedicine and biotechnology; import and export, and wholesale of mechanical equipment, electronic products, instrumentation, and plastic products. The company was founded on September 30, 2017 and is headquartered in Shanghai, China. | Health Technology |
Elpiscience Biopharmaceuticals, Inc.
Elpiscience Biopharmaceuticals, Inc. BiotechnologyHealth Technology Elpiscience Biopharmaceuticals, Inc. is an investment holding company, which engages in the research and development of immuno-oncology therapies. It focuses on the development of clinical-stage drug candidates namely, ES102, ES014, ES104, and ES009. The company was founded by Xiao Hui Ji and Hong Tao Lu in June 2017 and is headquartered in Shanghai, China. | Health Technology |
